$2.530
-0.010 (-0.39%)At close
Price Predictions
Open in app to unlock longer-horizon forecasts.
CLRB Prediction & Forecast by Similar Chart Analysis
Alphio's CLRB stock price prediction model matches the current Cellectar Biosciences Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $2.48 (-1.93%). The 1-week path is $2.63 (+3.91%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
Should I Buy Cellectar Biosciences Inc Stock?
Cellectar Biosciences Inc (CLRB) is a good buy right now due to its current price of $2.53, which is significantly below analyst price targets of $10 and $11, indicating potential upside. The company has reported a strong 87.5% overall response rate in its clinical trials, showcasing the efficacy of its treatment, which could lead to accelerated FDA approval. However, the main risk is its net income loss of $6.9 million in Q2 2026, which reflects ongoing financial challenges.
CLRB stock price ended at $2.53 on Friday, after losing -0.39%
Cellectar Biosciences Inc (CLRB) last closed at $2.53, losing -0.39%. These facts feed the 1-day and 1-week CLRB price prediction above.
Forecast Drivers
Cellectar Biosciences Inc (CLRB) forecast drivers combine similar chart patterns, seasonality, and moving averages.
Similar patterns
Bullish
Seasonality
Bearish
SMA 20
Bearish
SMA 200
Bearish
Similar Chart Patterns
Stocks whose recent price path most closely matches CLRB, ranked by similarity.
Seasonality analysis for CLRB
Historically the probability of a positive August return for CLRB is 0.00%. January offers the highest probability of a positive month at 50.82%, while August is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
10-year price projections for CLRB
| Month | Min Price | Avg Price | Max Price | Potential ROI |
|---|---|---|---|---|
| Aug 2026 | $5.11 | $5.37 | $6.39 | +112.38% |
| Sep 2026 | $3.62 | $4.45 | $4.48 | +76.03% |
| Oct 2026 | $4.74 | $4.94 | $5.19 | +95.34% |
| Nov 2026 | $4.46 | $4.66 | $4.73 | +84.10% |
| Dec 2026 | $5.12 | $5.89 | $6.85 | +132.98% |
In 2026, Cellectar Biosciences Inc (CLRB) is projected to range from $3.62 to $6.85.
Cellectar Biosciences Inc 2026 monthly forecast
In Aug 2026, Cellectar Biosciences Inc is projected to average $5.37, with a low of $5.11 and high of $6.39.
In Sep 2026, Cellectar Biosciences Inc is projected to average $4.45, with a low of $3.62 and high of $4.48.
In Oct 2026, Cellectar Biosciences Inc is projected to average $4.94, with a low of $4.74 and high of $5.19.
In Nov 2026, Cellectar Biosciences Inc is projected to average $4.66, with a low of $4.46 and high of $4.73.
In Dec 2026, Cellectar Biosciences Inc is projected to average $5.89, with a low of $5.12 and high of $6.85.
本ページは調査目的であり、投資助言ではありません。モデルは誤ることがあります。過去の実績は将来の成果を保証しません。